Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Anthocyanins, a class of flavonoid pigments found in various fruits and vegetables (especially berries), have garnered interest for their potential role in supporting or treating diabetic retinopathy (DR). Scientific research suggests that anthocyanins possess antioxidant, anti-inflammatory, and vasoprotective properties, which may be beneficial in the context of DR—a leading cause of vision loss in diabetic patients, primarily driven by oxidative stress, inflammation, and microvascular damage in the retina.

Several preclinical studies in animal models of diabetes have shown that anthocyanin supplementation can reduce retinal oxidative stress, inhibit inflammatory pathways, and protect retinal blood vessels from damage. For example, anthocyanins from bilberry (Vaccinium myrtillus) and blackcurrant have been shown to reduce capillary leakage and prevent pericyte loss in diabetic retinas. These effects are attributed to enhanced antioxidant enzyme activity and suppression of pro-inflammatory cytokines.

In terms of clinical evidence, the data is more limited but promising. A few small human studies and pilot clinical trials have reported improvements in retinal microcirculation and reductions in retinal edema or hemorrhages in diabetic patients taking anthocyanin-rich extracts. However, these studies often have methodological limitations (small sample sizes, short durations, lack of blinding), and larger, well-designed randomized controlled trials are needed to confirm efficacy and establish optimal dosing.

In summary, while the scientific rationale for anthocyanins in diabetic retinopathy is supported by mechanistic and early clinical data, the overall evidence base is moderate (3/5), and further research is required for conclusive recommendations.

More about anthocyanins
More about Diabetic Retinopathy

Other ingredients used for Diabetic Retinopathy

Other health conditions supported by anthocyanins

Products containing anthocyanins